These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 136805)
21. Anticoagulants in the treatment of cancer. Hilgard P; Thornes RD Eur J Cancer (1965); 1976 Oct; 12(10):755-62. PubMed ID: 789079 [No Abstract] [Full Text] [Related]
22. [Anticoagulant and fibrinolytic therapy of myocardial infarct]. Gritsiuk AI; Petrus' VG; Bol'shakova RM; Beliaeva KG Kardiologiia; 1973 Jan; 13(1):22-7. PubMed ID: 4272269 [No Abstract] [Full Text] [Related]
23. [Current data on diagnosis and treatment of thromboembolic states]. Zosin P; Roth L Med Interna (Bucur); 1972 Aug; 24(8):947-58. PubMed ID: 5080893 [No Abstract] [Full Text] [Related]
24. [Substantiation of anticoagulant and fibrinolysin therapy in the acute stage of chemical trauma of the esophagus]. Feĭgin GA Vestn Otorinolaringol; 1971; 33(4):71-5. PubMed ID: 4255828 [No Abstract] [Full Text] [Related]
25. Anticoagulant and fibrinolytic drugs - possible agents in treatment of lung cancer? Bobek V Anticancer Agents Med Chem; 2012 Jul; 12(6):580-8. PubMed ID: 22292773 [TBL] [Abstract][Full Text] [Related]
27. Anticoagulants and cancer. A review. Eichbaum FW Rev Bras Pesqui Med Biol; 1975; 8(5-6):489-96. PubMed ID: 769099 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants. Thornes RD Cancer; 1975 Jan; 35(1):91-7. PubMed ID: 1172718 [TBL] [Abstract][Full Text] [Related]
29. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity]. Fischer M Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030 [No Abstract] [Full Text] [Related]
30. [Current views on anticoagulant and fibrinolytic treatment in coronary arterial disease]. Wojczuk J Wiad Lek; 1971 Apr; 24(8):749-54. PubMed ID: 4252798 [No Abstract] [Full Text] [Related]
31. Mechanisms of establishment of tumor metastases. Wood S Pathobiol Annu; 1971; 1(0):281-308. PubMed ID: 4275752 [No Abstract] [Full Text] [Related]
32. [Effect of a combination of fibrinolysin, heparin and a fibrinolysin-heparin complex with dihydroergotoxine on thrombolysis]. Kalishevskaia TM; Golubeva MG; Bashkov GV; Vinter VB Fiziol Zh (1978); 1988; 34(3):88-93. PubMed ID: 2842201 [No Abstract] [Full Text] [Related]
33. Treatment of cerebrovascular thrombosis with plasmin and plasminogen activators. Meyer JS; Herndon RM; Johnson JF; Barnhart M Res Publ Assoc Res Nerv Ment Dis; 1966; 41():373-98. PubMed ID: 4224934 [No Abstract] [Full Text] [Related]
34. Experimental and clinical effects of anticoagulants on cancer progression. Van Noorden CJ; van Sluis GL; Spek CA Thromb Res; 2010 Apr; 125 Suppl 2():S77-9. PubMed ID: 20434011 [No Abstract] [Full Text] [Related]
35. [For and against the anticoagulants--for and against thrombolysis]. Gross R Internist (Berl); 1969 Jan; 10(1):1-2. PubMed ID: 4906436 [No Abstract] [Full Text] [Related]
37. [Functional significance of the clotting and anticlotting of the blood in the development of malignant neoplasms in the body]. Kudriashov BA; Kalishevskaia TM; Kolomina SM Usp Fiziol Nauk; 1979; 10(2):3-23. PubMed ID: 157648 [No Abstract] [Full Text] [Related]
38. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Gorelik E Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083 [TBL] [Abstract][Full Text] [Related]